^
Association details:
| Biomarker: | BRAF V600E |
|---|---|
| Cancer: | Ganglioglioma |
| Drug: | Cotellic (cobimetinib) (MEK1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Adjuvant Treatment...Useful in Certain Circumstance...Pilocytic astrocytoma, PXA, ganglioglioma if BRAF V600E activating mutation…cobimetinib
